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alpha interferon (IFN-a)-based therapies. However, the
antiviral mechanism of the cytokine against HCV remains
to be understood.
Methods: Established Huh7.5-BST2 cell lines were infected
with HCV at low (0.05) and high (3) MOI. Fluorescent
immunostaining, western blot, northern blot and viral titer
detection were used to analyze the dynamics of HCV
infection and virion production. siRNA targeting the mRNA
of BST2 was transfected into IFN-a treated Huh7.5 cells to
evaluate the role of BST2 on the effect of IFN-a against
HCV. High density (100% conﬂuent) and low density (25%
conﬂuent) cells were infected with HCV (MOI 0.05) with or
without CD81 antibody to test if BST2 inhibits HCV cell to
cell spread.
Results: We found that expression of an IFN-induced
cell membrane protein BST2 in Huh7.5 cells did not
apparently affect the efﬁciency of HCV infection and
genome replication, but signiﬁcantly reduced the yield
of virion production from the infected cells. In addition,
BST2 also dramatically inhibited the cell-to-cell transmission
of HCV in cultured Huh7.5 monolayers. Furthermore,
we demonstrated that inhibition of IFN-a-induced BST2
expression in Huh7.5 cells by siRNA technology compromised
the antiviral response of the cytokine against HCV.
Conclusions: Our results imply that BST2 is a functional
mediator of IFN response against HCV infection and inhibits
the release of HCV virions, which presumably buds from the
endoplasmic reticulum, but not plasma membrane.
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Full length NS2TP gene was ampliﬁed by PCR,
using prokaryotic expression plasmid pET32a(+)-NS2TP as
template, and cloned into the eukaryotic expressing
vector pEGFP-C1by DNA recombination technique. The
recombinant plasmid was identiﬁed by restriction enzyme
digestion, polymerase chain reaction and direct sequencing.
Then both the recombinant plasmid pEGFP-C1-NS2TP and
the control vector pEGFP-C1 were used to transfect HepG2
cell with Lipofectin 2000. After 30 h, the cells were
collected and NS2TP gene expression was proved by Western
blot analysis. Under the same culture conditions, both of
the HepG2 cell transfected with pEGFPC1-NS2TP and pEGFP-
C1 were collected after 30 h postransfection. Celltiter-Glo
luminescent cell viability assay showed that the growth of
hepG2 cells transfected with NS2TP gene was dramatically
inhibited compared with the parent hepG2 cells. These
results indicated that NS2TP could affect the cell growth of
HepG2 cell.
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Objective: To study the impact of gender on virologic
responses rates in genotype 1 CHC patients.
Methods: A matched retrospective cohort on 630 patients
treated with peginterferon and ribavirin was conducted.
The virologic response rates were compared between male
and female. The inﬂuential factors on SVR were studied
by multivariate analysis. In patients aged <40 years group,
the SVR rate of female was signiﬁcantly higher than that
of male (75.0%, 75/100 vs 54.0%, 54/100; P = 0.002); in
patients aged 40 50 years group, there was no signiﬁcant
difference in the SVR rate between male and female
(50.5%, 53/105 vs 54.3%, 57/105; P = 0.580); in patients aged
51 60 years group, the SVR rate of female was signiﬁcantly
lower than that of male (33.6%, 37/110 vs 48.2%, 53/110;
P = 0.028). In multivariate logistic regression analysis, the
independent factors associated with SVR of patients aged
51 60 years were sex (P = 0.013), 80% of planned ribavirin
dose (P = 0.008) and presence of RVR (P = 0.001).
Conclusions: In patients aged <40 years group, the SVR rate
of female is higher than that of male; in patients aged
40 50 years group, they share similar SVR rates; in patients
aged 51 60 years group the SVR rate of female is lower than
that of male.
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To evaluate the efﬁcacy of treatment with peginterferon
alfa-2a and ribavirin in elderly CHC patients and study the
inﬂuential factors related to SVR. The patients were divided
into two groups according to age: patients aged 65 years
(n = 140) and patients aged <65 years (n = 277). The virologic
response rates of two groups were compared.
Results: For genotype 1, patients aged 65 years had
signiﬁcantly higher relapse rate (50.0%, 42/84 vs 29.2%,
52/178; P = 0.001) and lower SVR rate (40.0%, 42/105 vs
60.0%, 126/210; P = 0.001) than patients aged <65 years.
For genotype 1, in patients aged 65 years, the SVR rate
of female patients was signiﬁcantly lower than that of
male patients (28.6%, 12/42 vs 47.6%, 30/63; P = 0.004).
In multivariate logistic regression analysis, the independent
factors associated with SVR of patients aged 65 years were
sex (P = 0.020), genotypes (P = 0.005), ribavirin reduction or
discontinuation (P = 0.009) and presence of rapid virologic
response (RVR) (P = 0.001).
Conclusions: The SVR rate of patients aged  65 years with
genotype 1 is low. Among patients 65 years old, genotype
2 patients and genotype 1 patients with a low baseline viral
load or achieving RVR or male may beneﬁt from combination
therapy.
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Objective: In 2009, three works published almost at
the same time studied the association between single
nucleotide polymorphisms near IL28B gene region and
treatment effect of pegylated-interferon (PegIFN) and
ribavirin (RVB) in HCV-infected patients. Many studies on
this issue with different HCV genotype and ethnic subjects
published subsequently. However, the conclusions about the
role of these polymorphisms are not identical. The aim
of this study was to quantify the impact of the IL28B
polymorphisms on the effect of HCV standard treatment
using meta-analysis based method.
